SOPHARMA AD - Annual Audited Consolidated Financial Statements of “Sopharma” AD

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. 097900BGGW0000048796-20241231-EN-CON.rarAnnual Audited Consolidated Financial Statements of “Sopharma” AD
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 14 / 2025

Date of issue: 2025-04-29

Short name of the issuer

SOPHARMA AD

Subject

Annual Audited Consolidated Financial Statements of “Sopharma” AD

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Sofia, Bulgaria, 29 April 2025 – According to the requirements of art. 100n of LPOS, “Sopharma” AD (SFA: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) presents the Annual Audited Consolidated Financial Statements,

Annexes

File Description

097900BGGW0000048796-20241231-EN-CON.rar097900BGGW0000048796-20241231-EN-CON.rar Annual Audited Consolidated Financial Statements of “Sopharma” AD

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2025-04-29 Ognian Donev Executive director